SCHEMBL29311292

SCHEMBL29311292

c1ccc(-c2nc3ccc(-c4nc(-c5ccc6c7ccccc7c7ccccc7c6c5)nc(-n5c6ccccc6c6ccccc65)n4)cc3s2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ NFKB1 P19838 2/20 0.47
▸ NFKB2 Q00653 2/20 0.47
▸ RELA Q04206 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ APP P05067 11/20 0.46
▸ MAPT P10636 6/20 0.46
▸ GAA P10253 5/20 0.46
▸ GLA P06280 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ PKM P14618 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ RAB9A P51151 5/20 0.42
▸ NPC1 O15118 4/20 0.42
▸ POLB P06746 2/20 0.42
▸ PAX8 Q06710 2/20 0.42
▸ MITF O75030 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459877 0.94 KDM4E (0.50) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL29311290 0.93 KDM4E (0.49) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL27049292 0.93 KDM4E (0.51) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL29311295 0.91 APP (0.47) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL29311291 0.91 KDM4E (0.47) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL27049592 0.91 KDM4E (0.47) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL29311350 0.91 RAB9A (0.42) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL29311300 0.90 KDM4E (0.44) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL29311299 0.90 KDM4E (0.46) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL29311294 0.88 KDM4E (0.43) KDM4ESMN1; SMN2NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-11 — — US disclosed
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND NLRP3, NLRP1, TYR KDM4E 1611/4885SMN1; SMN2 2040/4885NFKB1 1419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback